Moleculin Biotech, Inc.
Key Metrics
Market Snapshot
About
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company developing oncology drug candidates for resistant and difficult-to-treat tumors. The company focuses on novel anti-tumor agents targeting highly refractory cancers, including glioblastoma, pancreatic cancer, and acute myeloid leukemia. Their pipeline includes small molecules designed to disrupt multiple tumor defense mechanisms simultaneously.